Yao‐Li Cui

474 total citations
16 papers, 335 citations indexed

About

Yao‐Li Cui is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yao‐Li Cui has authored 16 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Yao‐Li Cui's work include Liver Disease Diagnosis and Treatment (4 papers), Inflammasome and immune disorders (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yao‐Li Cui is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Inflammasome and immune disorders (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yao‐Li Cui collaborates with scholars based in China, Canada and United States. Yao‐Li Cui's co-authors include Maobin Meng, Ruiming Zhang, Yong‐Song Guan, Ming‐Hua Zheng, You Lü, Yan Chen, Hong Tang, Yuebin Wang, Li Liu and Xue-Zhong Lei and has published in prestigious journals such as Frontiers in Immunology, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Yao‐Li Cui

15 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yao‐Li Cui China	10	198	138	73	62	39	16	335
Tomohiro Katsumi Japan	12	179 0.9×	145 1.1×	77 1.1×	78 1.3×	25 0.6×	27	330
Mariagrazia Del Buono Italy	6	216 1.1×	156 1.1×	63 0.9×	84 1.4×	52 1.3×	6	341
Dirk Michels Germany	6	235 1.2×	218 1.6×	76 1.0×	64 1.0×	37 0.9×	8	417
Yiqi Cai China	10	133 0.7×	146 1.1×	48 0.7×	78 1.3×	67 1.7×	32	318
Andrea Thüringer Austria	8	117 0.6×	117 0.8×	61 0.8×	100 1.6×	94 2.4×	11	302
Chia-Long Lee Taiwan	9	87 0.4×	99 0.7×	86 1.2×	124 2.0×	56 1.4×	12	319
Maria Francesca Secchi Italy	7	127 0.6×	108 0.8×	127 1.7×	58 0.9×	28 0.7×	8	340
Yuta Wakui Japan	13	199 1.0×	276 2.0×	88 1.2×	43 0.7×	48 1.2×	23	467
Zuyuan Lin China	10	96 0.5×	96 0.7×	129 1.8×	70 1.1×	57 1.5×	29	326
Antony Aziz United States	10	176 0.9×	113 0.8×	85 1.2×	206 3.3×	21 0.5×	19	398

Countries citing papers authored by Yao‐Li Cui

Since Specialization

Citations

This map shows the geographic impact of Yao‐Li Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao‐Li Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao‐Li Cui more than expected).

Fields of papers citing papers by Yao‐Li Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao‐Li Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao‐Li Cui. The network helps show where Yao‐Li Cui may publish in the future.

Co-authorship network of co-authors of Yao‐Li Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yao‐Li Cui. A scholar is included among the top collaborators of Yao‐Li Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao‐Li Cui. Yao‐Li Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cui, Yao‐Li, et al.. (2025). Acevaltrate overcomes myeloma resistance to bortezomib via pyroptosis by promoting BAX translocalization to mitochondria. European Journal of Pharmacology. 996. 177572–177572.

Cui, Yao‐Li, Xue Han, Wei Li, et al.. (2025). Comprehensive Analysis of Single‐Cell and Bulk Transcriptomics Identified Regulatory T‐Cell Features as Predictors of Prognosis in Diffuse Large B‐Cell Lymphoma. Hematological Oncology. 43(2). e70050–e70050. 1 indexed citations

He, Yuanming, Shuoyi Jiang, Yao‐Li Cui, et al.. (2024). Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis. Cancer Letters. 588. 216797–216797. 7 indexed citations

He, Yuanming, et al.. (2023). Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX/GSDME pathway. Acta Pharmacologica Sinica. 44(7). 1464–1474. 16 indexed citations

He, Yuanming, Shuoyi Jiang, Xiaoge Wang, et al.. (2023). USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl. Clinical and Translational Medicine. 13(12). e1509–e1509. 19 indexed citations

Zhang, Tingting, Hengqi Liu, Fenghua Gao, et al.. (2022). m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. Frontiers in Immunology. 13. 922471–922471. 7 indexed citations

Sun, Bingsheng, Yongchun Song, Dong Yang, et al.. (2022). Risk‐adapted stereotactic body radiotherapy for patients with cervical spinal metastases. Cancer Science. 113(12). 4277–4288. 3 indexed citations

Cui, Yao‐Li, et al.. (2016). Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia. Patient Preference and Adherence. 10. 313–313. 17 indexed citations

Du, Lingyao, Yao‐Li Cui, En‐Qiang Chen, et al.. (2014). Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment. Virology Journal. 11(1). 51–51. 14 indexed citations

10.

Meng, Maobin, et al.. (2010). Meta-analysis: Traditional Chinese Medicine for Improving Immune Response in Patients With Unresectable Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. EXPLORE. 7(1). 37–43. 23 indexed citations

11.

Cui, Yao‐Li, Yuebin Wang, Xueqin Song, et al.. (2010). Nucleoside Analogue Can Improve the Long-Term Prognosis of Patients with Hepatitis B Virus Infection-Associated Acute on Chronic Liver Failure. Digestive Diseases and Sciences. 55(8). 2373–2380. 68 indexed citations

12.

Meng, Maobin, Yao‐Li Cui, Yong‐Song Guan, et al.. (2008). Traditional Chinese Medicine Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma. The Journal of Alternative and Complementary Medicine. 14(8). 1027–1042. 26 indexed citations

13.

Zheng, Ming‐Hua, Hailong Lin, Li‐Xin Qiu, et al.. (2008). Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure. Cytotherapy. 11(3). 326–329. 10 indexed citations

14.

Meng, Maobin, Yao‐Li Cui, You Lü, et al.. (2008). Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Radiotherapy and Oncology. 92(2). 184–194. 107 indexed citations

15.

Cui, Yao‐Li, Maobin Meng, Hong Tang, et al.. (2008). Recombinant human hepatocyte growth factor for liver failure. Contemporary Clinical Trials. 29(5). 696–704. 14 indexed citations

16.

Zheng, Ming‐Hua, Yongning Xin, Hai Li, et al.. (2008). Probiotics: A possible specific liver drug for non-alcoholic fatty liver disease. 2(1). 54–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact